{
    "data": [
        {
            "id": "4394221",
            "type": "article",
            "attributes": {
                "publishOn": "2020-12-11T06:41:42-05:00",
                "isLockedPro": false,
                "commentCount": 8,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Strong Fundamentals In The Animal Health Industry Will Drive Zoetis Shares To $200 And Beyond",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "105317",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "304243",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "94801",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4394221-strong-fundamentals-in-animal-health-industry-will-drive-zoetis-shares-to-200-and-beyond"
            }
        },
        {
            "id": "4389631",
            "type": "article",
            "attributes": {
                "publishOn": "2020-11-17T08:49:24-05:00",
                "isLockedPro": false,
                "commentCount": 13,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Zoetis: Sales Growth Rebounded To 15% In Q3 But P/E Is Now 43x",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "105096",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "301071",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "94801",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4389631-zoetis-sales-growth-rebounded-to-15-percent-in-q3-p-e-is-now-43x"
            }
        },
        {
            "id": "4378613",
            "type": "article",
            "attributes": {
                "publishOn": "2020-10-12T09:41:00-04:00",
                "isLockedPro": false,
                "commentCount": 0,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "The Bull Case For ZTS, U, FLWS, And QRTEA (Video)",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "24103",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "296012",
                            "type": "sentiment"
                        },
                        {
                            "id": "296013",
                            "type": "sentiment"
                        },
                        {
                            "id": "296014",
                            "type": "sentiment"
                        },
                        {
                            "id": "296015",
                            "type": "sentiment"
                        },
                        {
                            "id": "296016",
                            "type": "sentiment"
                        },
                        {
                            "id": "296017",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "94801",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4378613-bull-case-for-zts-u-flws-and-qrtea-video"
            }
        },
        {
            "id": "4373399",
            "type": "article",
            "attributes": {
                "publishOn": "2020-09-10T10:00:00-04:00",
                "isLockedPro": false,
                "commentCount": 12,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Zoetis: Strong, Resilient, But Too Expensive For Me",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "50662",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "291624",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "94801",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4373399-zoetis-strong-resilient-too-expensive-for-me"
            }
        },
        {
            "id": "4373302",
            "type": "article",
            "attributes": {
                "publishOn": "2020-09-09T14:03:55-04:00",
                "isLockedPro": false,
                "commentCount": 4,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Zoetis: Downgrade To Neutral On Valuation After 37% Gain",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "105096",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "291700",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "94801",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4373302-zoetis-downgrade-to-neutral-on-valuation-after-37-percent-gain"
            }
        },
        {
            "id": "4352966",
            "type": "article",
            "attributes": {
                "publishOn": "2020-06-09T23:23:15-04:00",
                "isLockedPro": false,
                "commentCount": 8,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Zoetis Now A Better Buy Than Gilead",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "23468",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "278735",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "94801",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4352966-zoetis-now-better-buy-gilead"
            }
        },
        {
            "id": "4343837",
            "type": "article",
            "attributes": {
                "publishOn": "2020-05-06T18:57:19-04:00",
                "isLockedPro": false,
                "commentCount": 5,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Zoetis: Good Time To Start Building Position In This Animal Health Player",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "102293",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "274182",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "94801",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4343837-zoetis-good-time-to-start-building-position-in-this-animal-health-player"
            }
        },
        {
            "id": "4330745",
            "type": "article",
            "attributes": {
                "publishOn": "2020-03-10T08:00:00-04:00",
                "isLockedPro": false,
                "commentCount": 15,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Zoetis: Continuing Resilience And Compounding At 10%+ Annually",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "105096",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "264575",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "94801",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": [
                        {
                            "id": "1302",
                            "type": "tag"
                        }
                    ]
                }
            },
            "links": {
                "self": "/article/4330745-zoetis-continuing-resilience-and-compounding-10-percent-annually"
            }
        },
        {
            "id": "4329656",
            "type": "article",
            "attributes": {
                "publishOn": "2020-03-04T16:58:54-05:00",
                "isLockedPro": false,
                "commentCount": 6,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Markets Irrationally React To Coronavirus, Creating Buying Opportunity For Zoetis",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "105317",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "263752",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "94801",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4329656-markets-irrationally-react-to-coronavirus-creating-buying-opportunity-for-zoetis"
            }
        },
        {
            "id": "4317648",
            "type": "article",
            "attributes": {
                "publishOn": "2020-01-17T14:39:09-05:00",
                "isLockedPro": false,
                "commentCount": 6,
                "gettyImageUrl": null,
                "videoPreviewUrl": null,
                "videoDuration": null,
                "themes": {},
                "title": "Still Very Bullish On Zoetis After Presentation At J.P. Morgan Healthcare Conference",
                "structuredInsights": null,
                "isPaywalled": false
            },
            "relationships": {
                "author": {
                    "data": {
                        "id": "105317",
                        "type": "author"
                    }
                },
                "sentiments": {
                    "data": [
                        {
                            "id": "255158",
                            "type": "sentiment"
                        }
                    ]
                },
                "primaryTickers": {
                    "data": [
                        {
                            "id": "94801",
                            "type": "tag"
                        }
                    ]
                },
                "secondaryTickers": {
                    "data": []
                },
                "otherTags": {
                    "data": []
                }
            },
            "links": {
                "self": "/article/4317648-still-bullish-on-zoetis-after-presentation-j-p-morgan-healthcare-conference"
            }
        }
    ]
}